1. Home
  2. NOTV vs EVG Comparison

NOTV vs EVG Comparison

Compare NOTV & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • EVG
  • Stock Information
  • Founded
  • NOTV 1974
  • EVG 2005
  • Country
  • NOTV United States
  • EVG United States
  • Employees
  • NOTV N/A
  • EVG N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • EVG Investment Managers
  • Sector
  • NOTV Health Care
  • EVG Finance
  • Exchange
  • NOTV Nasdaq
  • EVG Nasdaq
  • Market Cap
  • NOTV 137.5M
  • EVG 144.8M
  • IPO Year
  • NOTV 1997
  • EVG N/A
  • Fundamental
  • Price
  • NOTV $1.96
  • EVG $10.95
  • Analyst Decision
  • NOTV Strong Buy
  • EVG
  • Analyst Count
  • NOTV 3
  • EVG 0
  • Target Price
  • NOTV $6.25
  • EVG N/A
  • AVG Volume (30 Days)
  • NOTV 840.6K
  • EVG 49.4K
  • Earning Date
  • NOTV 05-07-2025
  • EVG 01-01-0001
  • Dividend Yield
  • NOTV N/A
  • EVG 8.68%
  • EPS Growth
  • NOTV N/A
  • EVG N/A
  • EPS
  • NOTV N/A
  • EVG N/A
  • Revenue
  • NOTV $480,402,000.00
  • EVG N/A
  • Revenue This Year
  • NOTV $5.84
  • EVG N/A
  • Revenue Next Year
  • NOTV $5.74
  • EVG N/A
  • P/E Ratio
  • NOTV N/A
  • EVG N/A
  • Revenue Growth
  • NOTV N/A
  • EVG N/A
  • 52 Week Low
  • NOTV $1.15
  • EVG $9.13
  • 52 Week High
  • NOTV $6.48
  • EVG $10.86
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 47.15
  • EVG 55.12
  • Support Level
  • NOTV $1.75
  • EVG $10.80
  • Resistance Level
  • NOTV $2.36
  • EVG $10.99
  • Average True Range (ATR)
  • NOTV 0.18
  • EVG 0.19
  • MACD
  • NOTV 0.07
  • EVG 0.03
  • Stochastic Oscillator
  • NOTV 45.95
  • EVG 82.14

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

Share on Social Networks: